Sabrina Poulos

The USPTO Proposes A Radical Change To Terminal Disclaimer Practice: You Have An Opportunity To Comment

The Appeals Review Panel's In Re Xencor Decision: The USPTO Provides Its Position On Written Description And Means-Plus-Function Claims

Janssen v. Teva: Not An April Fool's Day Joke For Life Sciences Companies

USPTO Emphasizes Searches Of FDA Databases For Pharmaceutical Patent Applications

USPTO's New Guidance On AI-Assisted Inventions: The Impact On The Use Of AI In The Life Sciences

Life Sciences Companies Make Up A Small Portion Of The Companies Opting-In To The Unitary Patent; Ireland Announces Referendum Date

USPTO Publishes Enablement Guidelines In View Of Amgen v. Sanofi

Federal Circuit Remands To USPTO To Clarify Analysis Of Jepson-Format And Means-Plus-Function Claims In The Field Of Biotechnology

K-Fee Provides A Warning To Life Sciences Companies – What You Say In Foreign Prosecution May Affect Your U.S. Claim Scope

District Court Grants Summary Judgment And Invalidates Patent In REGENXBIO v. Sarepta Litigation